Skip to main content
Caplight Logo









Bioleap

Bioleap

Private
CambridgeHealthcare & Life Scienceshttps://www.bioleap.ai/

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Bioleap is a biotechnology company that develops an AI-powered, physics-first biosimulation platform to accelerate drug discovery and the development of complex biologics.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Medical AI, Clinical Trials, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Subscription SaaS

AI Layer

Application

Keywords

biosimulationin-silico drug discoverymechanistic modelingquantitative systems pharmacologyQSPhybrid-AIpatient stratificationimmuno-oncologybiologics developmentdigital twincomputational biologyclinical trial optimizationAI drug discoverypharma R&D softwarebiotech consulting

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Bioleap Comparables

Compare Bioleap with similar companies based on industry and business-model similarity.

Bioleap comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Netabolics
87%
VeriSIM Life
82%
InSysBio
79%

Bioleap Funding Rounds

Historical fundraising activity

View Full Funding History

Access detailed round history, amounts raised, valuations, and investors.

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 25, 2026

    Monthly visitors grew 205% MoM, reaching 999.

Bioleap Filings

Explore SEC and related filing metadata, where available.

Bioleap filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Bioleap's valuation, stock price, and market status.

Is Bioleap a public or private company?

Bioleap is a private company.

What is the current stock price of Bioleap?

Bioleap is a private company with no public stock price. Caplight tracks Bioleap's secondary market activity and provides MarketPrice estimates to Caplight users.

How much is Bioleap worth (valuation)?

Valuation information for Bioleap is not publicly available.

Can I buy Bioleap stock?

Bioleap shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Bioleap's last funding round?

Funding round information for Bioleap is not publicly available.

Who are the main investors in Bioleap?

Investor information for Bioleap is not publicly disclosed.

Will Bioleap IPO soon?

No public IPO plans have been announced for Bioleap.

How can I track Bioleap secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Bioleap's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersCambridge
Employee Range2
Year Founded2022
Last Funding—

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?